Freedom Acquisition 1 (FACT) Announces $1Bn LOI with Human Longevity
Freedom Acquisition 1 (NYSE:FACT) announced over the long weekend that it has signed a non-binding letter of intent (LOI) to combine with genome sequencing firm Human Longevity, Inc. valued at $1 billion.
...READ MORE